VivoSim Labs, INC. (VIVS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 03-31. Amounts in USD.

Revenue Quarterly

0 600K 1.2M 1.8M Q2 '17: 1.4M Q3 '17: 1.2M Q4 '17: 812K Q1 '18: 990K Q2 '18: 1.4M Q3 '18: 1.2M Q4 '18: 1.1M Q1 '19: 689K Q2 '19: 943K Q3 '19: 779K Q4 '19: 680K Q1 '20: 668K Q2 '20: 1.2M Q3 '20: 298K Q4 '20: 0 Q1 '21: 0 Q2 '21: 0 Q3 '21: 0 Q4 '21: 0 Q1 '22: 0 Q2 '22: 0 Q3 '22: 0 Q4 '22: 1.5M Q1 '23: 0 Q2 '23: 77K Q3 '23: 131K Q4 '23: 162K Q1 '24: 75K Q2 '24: 0 Q3 '24: 5K Q4 '24: 29K Q1 '25: 39K Q2 '25: 30K Q3 '25: 24K Q4 '25: 51K Q1 '26: 37K Q2 '26: 28K Q3 '26: 26K Q4 '26: 40K Q1 '27: 18K Q2 '18 Q3 '19 Q4 '20 Q1 '22 Q2 '23 Q3 '24 Q4 '25 Q1 '27

Gross Profit Quarterly

0 400K 800K 1.2M Q1 '18: 689K Q2 '18: 1.1M Q3 '18: 961K Q4 '18: 822K Q1 '19: 569K Q2 '19: 818K Q3 '19: 643K Q4 '19: 579K Q1 '20: 617K Q2 '20: 966K Q3 '20: 285K Q4 '20: 0 Q1 '21: 0 Q2 '21: 0 Q3 '21: 0 Q4 '21: 0 Q1 '24: 75K Q2 '24: 0 Q3 '24: 5K Q1 '25: 37K Q2 '25: 29K Q3 '25: 22K Q4 '25: 51K Q1 '26: 37K Q2 '26: 28K Q3 '26: 26K Q4 '26: 40K Q3 '18 Q3 '19 Q3 '20 Q3 '21 Q3 '24 Q4 '25 Q4 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-12M -8M -4M 0 4M 8M 12M Q2 '17: -9.5M Q3 '17: -9.6M Q4 '17: -10.7M Q1 '18: -10.2M Q2 '18: -9.6M Q3 '18: -7.9M Q4 '18: -7.6M Q1 '19: -7.6M Q2 '19: -6M Q3 '19: -6.5M Q4 '19: -7.2M Q1 '20: -6.5M Q2 '20: -6.8M Q3 '20: -5.2M Q4 '20: -2.9M Q1 '21: -2.8M Q2 '21: -8.9M Q3 '21: -2.5M Q4 '21: -2.6M Q1 '22: -2.6M Q2 '22: -3.5M Q3 '22: -3.5M Q4 '22: -1.9M Q1 '23: -3.2M Q2 '23: -3.4M Q3 '23: -3.4M Q4 '23: -7.8M Q1 '24: -4.2M Q2 '24: -4.1M Q3 '24: -3.7M Q4 '24: -3.1M Q1 '25: -3.4M Q2 '25: -2.6M Q3 '25: -3.5M Q4 '25: -3.2M Q1 '26: -2.9M Q2 '26: -2.6M Q3 '26: -2.8M Q4 '26: -3.2M Q1 '27: -2.8M Q2 '18 Q3 '19 Q4 '20 Q1 '22 Q2 '23 Q3 '24 Q4 '25 Q1 '27

Net Income Quarterly

-12M -8M -4M 0 4M 8M 12M Q2 '17: -9.4M Q3 '17: -9.6M Q4 '17: -10.7M Q1 '18: -10.1M Q2 '18: -9.5M Q3 '18: -7.8M Q4 '18: -7.4M Q1 '19: -7.4M Q2 '19: -5.8M Q3 '19: -6.4M Q4 '19: -7M Q1 '20: -6.3M Q2 '20: -6.3M Q3 '20: -3.4M Q4 '20: -2.7M Q1 '21: -2.8M Q2 '21: -8.9M Q3 '21: -2.5M Q4 '21: -2.6M Q1 '22: -2.5M Q2 '22: -3.5M Q3 '22: -3.5M Q4 '22: -1.9M Q1 '23: -3.2M Q2 '23: -3.3M Q3 '23: -3.3M Q4 '23: -7.5M Q1 '24: -4M Q2 '24: -4M Q3 '24: -3.6M Q4 '24: -3M Q1 '25: -3.3M Q2 '25: -2.5M Q3 '25: -3.4M Q4 '25: 6.9M Q1 '26: -2.8M Q2 '26: -2.5M Q3 '26: -2.7M Q4 '26: -5.8M Q1 '27: -1.3M Q2 '18 Q3 '19 Q4 '20 Q1 '22 Q2 '23 Q3 '24 Q4 '25 Q1 '27

Cost of Revenue Quarterly

0 150K 300K 450K Q1 '16: 0 Q2 '16: 0 Q3 '16: 0 Q4 '16: 0 Q1 '17: 168K Q2 '17: 393K Q3 '17: 212K Q4 '17: 183K Q1 '18: 301K Q2 '18: 254K Q3 '18: 192K Q4 '18: 283K Q1 '19: 120K Q2 '19: 125K Q3 '19: 136K Q4 '19: 101K Q1 '20: 51K Q2 '20: 264K Q3 '20: 13K Q4 '20: 0 Q1 '21: 0 Q2 '21: 0 Q3 '21: 0 Q4 '21: 0 Q1 '24: 0 Q2 '24: 0 Q3 '24: 0 Q1 '25: 2K Q2 '25: 1K Q3 '25: 2K Q4 '25: 0 Q1 '26: 0 Q2 '26: 0 Q3 '26: 0 Q4 '26: 0 Q1 '17 Q2 '18 Q3 '19 Q4 '20 Q1 '24 Q3 '25 Q4 '26

Operating Cash Flow Quarterly

-12M -8M -4M 0 4M 8M 12M Q2 '17: -6.4M Q3 '17: -7M Q4 '17: -7.2M Q1 '18: -10.7M Q2 '18: -6.1M Q3 '18: -6.4M Q4 '18: -5.6M Q1 '19: -7M Q2 '19: -4.3M Q3 '19: -4M Q4 '19: -5.1M Q1 '20: -5.9M Q2 '20: -5.2M Q3 '20: -583K Q4 '20: -3.2M Q1 '21: -2.6M Q2 '21: -7.1M Q3 '21: -1.5M Q4 '21: -2.1M Q1 '22: -1.4M Q2 '22: -2.1M Q3 '22: -3.4M Q4 '22: -1.5M Q1 '23: -2.4M Q2 '23: -2.2M Q3 '23: -3M Q4 '23: -4.7M Q1 '24: -5.3M Q2 '24: -3.1M Q3 '24: -3.5M Q4 '24: -2.7M Q1 '25: -3M Q2 '25: -2.6M Q3 '25: -1.8M Q4 '25: -2M Q1 '26: -3.9M Q2 '26: -2.4M Q3 '26: -2.3M Q4 '26: -2.2M Q1 '27: -3.2M Q2 '18 Q3 '19 Q4 '20 Q1 '22 Q2 '23 Q3 '24 Q4 '25 Q1 '27

Free Cash Flow Quarterly

-12M -8M -4M 0 4M 8M 12M Q4 '16: -7.9M Q1 '17: -8.6M Q2 '17: -6.8M Q3 '17: -7.7M Q4 '17: -7.5M Q1 '18: -10.7M Q2 '18: -6.2M Q3 '18: -6.5M Q4 '18: -5.7M Q1 '19: -7M Q2 '19: -4.3M Q3 '19: -4M Q4 '19: -5.1M Q3 '20: -583K Q4 '20: -3.2M Q1 '21: -2.6M Q2 '21: -7.1M Q3 '21: -1.8M Q4 '21: -2.2M Q1 '22: -1.6M Q2 '22: -2.2M Q3 '22: -3.5M Q4 '22: -1.6M Q1 '23: -2.5M Q2 '23: -2.3M Q3 '23: -3.1M Q4 '23: -4.9M Q1 '24: -5.3M Q2 '24: -3.2M Q3 '24: -3.5M Q4 '24: -2.7M Q1 '25: -3M Q2 '25: -2.7M Q3 '25: -1.8M Q4 '25: -2M Q1 '26: -3.9M Q2 '26: -2.4M Q3 '26: -2.3M Q4 '26: -2.2M Q1 '27: -3.2M Q4 '17 Q1 '19 Q4 '20 Q1 '22 Q2 '23 Q3 '24 Q4 '25 Q1 '27

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q2 '12: 12.3M Q2 '13: 55.8M Q2 '14: 72.7M Q1 '22: 8.7M Q2 '22: 8.7M Q3 '22: 8.7M Q1 '23: 8.7M Q2 '23: 8.7M Q3 '23: 8.7M Q1 '24: 8.7M Q2 '24: 8.7M Q3 '24: 9.1M Q1 '25: 1.2M Q2 '25: 1.5M Q3 '25: 1.5M Q1 '26: 2.5M Q2 '26: 2.6M Q3 '26: 2.6M Q1 '27: 5.2M Q2 '12 Q1 '22 Q1 '23 Q1 '24 Q1 '25 Q1 '26 Q1 '27

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-27.00 -18.00 -9.00 0.00 9.00 18.00 27.00 Q2 '17: -0.39 Q3 '17: -0.37 Q4 '17: -0.38 Q1 '18: -0.39 Q2 '18: -0.38 Q3 '18: -0.36 Q4 '18: -0.33 Q1 '19: -0.30 Q2 '19: -0.26 Q3 '19: -0.25 Q4 '19: -0.24 Q1 '20: -0.22 Q2 '20: -1.17 Q3 '20: -1.71 Q4 '20: -2.05 Q1 '21: -2.40 Q2 '21: -2.76 Q3 '21: -2.53 Q4 '21: -2.43 Q1 '22: -2.32 Q2 '22: -1.36 Q3 '22: -1.39 Q4 '22: -1.31 Q1 '23: -1.39 Q2 '23: -1.37 Q3 '23: -1.34 Q4 '23: -1.97 Q1 '24: -2.06 Q2 '24: -2.14 Q3 '24: -2.17 Q4 '24: -19.26 Q1 '25: -21.54 Q2 '25: -22.76 Q3 '25: -24.64 Q4 '25: -1.70 Q1 '26: -0.10 Q2 '26: 0.60 Q3 '26: 1.85 Q4 '26: -5.36 Q1 '27: -4.47 Q2 '18 Q3 '19 Q4 '20 Q1 '22 Q2 '23 Q3 '24 Q4 '25 Q1 '27

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.